In this episode of Causes or Cures, Dr. Eeks chats with Dr. Karen Van Nuys and Dr. Neeraj Sood about the pricing of insulin in the United States. It's no secret that insulin is unaffordable for many Americans who need it. This discussion will center around how the price of insulin is set, all the players involved, and who is to blame for the high price of insulin in the US. We will explore who benefits the most from increasing insulin prices, whether or not the Inflation Reduction Act will make a significant difference, and what can practically be done to make insulin more affordable for more Americans.
Dr. Van Nuys is the executive director of the Value of Life Sciences Innovation program and a fellow at the USC Schaeffer Center. She is also a research assitant professor at the USC Price School of Public Policy. You can learn more about her work here.
Dr. Sood is a professor at the USC Price School of Public Policy with joint appointments at the USC Keck School of Medicine and USC Marshall School of Business. He is also a senior fellow at the USC Schaeffer center and you can learn more about his work here.
You can contact Dr. Eeks at bloomingwellness.com.
Follow Dr. Eeks on Instagram here.
Or Facebook here.
Or Twitter.
Subcribe to her newsletter here.
Thanks for listening! :)